Dongkoo Bio&Pharma, top sales company in dermatology, working on IPO

Published: 2017-05-30 13:49:15

Updated: 2017-05-30 13:49:15

Dongkoo Bio&Pharma(CEO Yong-Joon Cho) has selected NH Investment & Securities as its stock firm and gotten on an IPO process by filing a screening to the Korea Exchange on the 25^th. The amount of stocks expected to be issued is 2,069,120 stocks.

Dongkoo Bio&Pharma, a pharmaceutical company founded in 1970 as Dongkoo Pharm and showing strengths in the dermatology(1^st for 8 years) and urology fi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.